Limosilactobacillus reuteri in Human Health and Disease
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Gastroenterology & Hepatology".
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 21510
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue aims to become an overview of the currently available knowledge and recent findings regarding the role of Limosilactobacillus reuteri (formerly known as Lactobacillus reuteri) in health and disease.
L. reuteri is one of the most scientifically well-documented probiotics in the world.
In humans, L. reuteri is found in different body sites, including the gastrointestinal tract, urinary tract, skin, and breast milk.
Direct supplementation or prebiotic modulation of L. reuteri could be an option in the prevention and/or therapy of many inflammatory diseases.
A broad spectrum of subtopics will be covered, ranging from gastrointestinal to non-gastrointestinal diseases in both adults and children.
The subtopics to be covered within this Issue are listed below:
- Role of L. reuteri in diarrhea;
- Role of L. reuteri in constipation;
- Role of L. reuteri in Helicobacter pylori infection;
- Role of L. reuteri in periodontal disease;
- Role of probiotics in general health;
- Role of L. reuteri during PPI treatment;
- Role of L. reuteri in functional abdominal pain in children;
- Role of L. reuteri in diabetic patients;
- Role of L. reuteri in acute uncomplicated diverticulitis;
- The efficacy and characteristics of different L. reuteri strains;
- Role of L. reuteri in antibiotic-associated diarrhea (AAD);
- Role of L. reuteri in kidney diseases.
Dr. Veronica Ojetti
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Lactobacillus reuteri
- Lactobacillus reuteri and gastrointestinal diseases
- Lactobacillus reuteri and extragastrointestinal diseases